<p>Mice with xenografts were treated for 11 days. Treatments: control (CTL) did not receive any treatment but tumor bearing mice (10<sup>th</sup> day after tumor implantation) were injected with photofrin (10 mg/kg) by tail vein, and 24 h later, 670 nm light was delivered to the tumor with fluencies of 100 J/cm<sup>2</sup> at a fluency rate of 50 mW/cm<sup>2</sup>. We used 100 J/cm<sup>2</sup> to expose most of the tumor cells to radiation (32). Then, the mixture of miR-99a mimic (50 µg) and 0.05% atelocollagen in 200 µl was injected (via tail vein) into each mouse on 14<sup>th</sup>, 17<sup>th</sup>, and 20<sup>th</sup> days. All animals were sacrificed on 21<sup>st</sup> day. Representative Western blots (<i>n</i>≥3) showed expression of ...
<p>(A) Tumor xenograft growth of HCT-116 and HCT-116<sup>miR-211</sup> are shown under a light and f...
<p>(A) KYSE70 cells were treated with the indicated concentrations of CYT-Rx20, followed by evaluati...
<p>A, image of tumor-xenografted nude mice model at the end of the treatment. B, tumor size growth c...
<p>(A) miR-1228* was more than ten-fold changes in miR-1228* stable transfected SGC-7901 compared wi...
<p>(<b>A</b>) Tumor tissues were removed and measured 15 days after engraftment. (<b>B</b>) Growth c...
<p>(<b>A</b>) <i>In vivo</i> monitoring of xenograft tumor progression: MIA PaCa-2 cells expressing ...
<p>A, Schematic illustration of the schedule of xenografted mice experiments using HEK293-FLAG-hCD10...
<p>(<b>A</b>) Effect ofmiR-30b on tumor formation in vivo xenograft mode. miR-control- and miR-30b-t...
<p>(<b>A</b>) ICR-nude mice bearing the established A549 tumors (∼50 mm<sup>3</sup>) were treated wi...
<p>Female nude mice bearing MDA-MB-231 tumors were treated with either vehicle (control) or the comp...
<p>Tumor growth of SCID mice implanted with Luc or GFP expressing A2780<sup>R2000</sup> cells. (A) B...
<p>Mice bearing i.p. LS-174T xenografts were treated by Pac/<sup>212</sup>Pb-trastuzumab for 24 h. q...
<p>(<b>A</b>) Xenograft tumor growth in nude mice. A total of 1 x 10<sup>6</sup> U87MG cells transfe...
(A) Timeline of cell inoculation, drug administration and monitoring of tumor growth. For evaluation...
<div><p>The therapeutic effect of 13-MTD on Jurkat cell xenografts.</p> <p>The tumor volumes of xeno...
<p>(A) Tumor xenograft growth of HCT-116 and HCT-116<sup>miR-211</sup> are shown under a light and f...
<p>(A) KYSE70 cells were treated with the indicated concentrations of CYT-Rx20, followed by evaluati...
<p>A, image of tumor-xenografted nude mice model at the end of the treatment. B, tumor size growth c...
<p>(A) miR-1228* was more than ten-fold changes in miR-1228* stable transfected SGC-7901 compared wi...
<p>(<b>A</b>) Tumor tissues were removed and measured 15 days after engraftment. (<b>B</b>) Growth c...
<p>(<b>A</b>) <i>In vivo</i> monitoring of xenograft tumor progression: MIA PaCa-2 cells expressing ...
<p>A, Schematic illustration of the schedule of xenografted mice experiments using HEK293-FLAG-hCD10...
<p>(<b>A</b>) Effect ofmiR-30b on tumor formation in vivo xenograft mode. miR-control- and miR-30b-t...
<p>(<b>A</b>) ICR-nude mice bearing the established A549 tumors (∼50 mm<sup>3</sup>) were treated wi...
<p>Female nude mice bearing MDA-MB-231 tumors were treated with either vehicle (control) or the comp...
<p>Tumor growth of SCID mice implanted with Luc or GFP expressing A2780<sup>R2000</sup> cells. (A) B...
<p>Mice bearing i.p. LS-174T xenografts were treated by Pac/<sup>212</sup>Pb-trastuzumab for 24 h. q...
<p>(<b>A</b>) Xenograft tumor growth in nude mice. A total of 1 x 10<sup>6</sup> U87MG cells transfe...
(A) Timeline of cell inoculation, drug administration and monitoring of tumor growth. For evaluation...
<div><p>The therapeutic effect of 13-MTD on Jurkat cell xenografts.</p> <p>The tumor volumes of xeno...
<p>(A) Tumor xenograft growth of HCT-116 and HCT-116<sup>miR-211</sup> are shown under a light and f...
<p>(A) KYSE70 cells were treated with the indicated concentrations of CYT-Rx20, followed by evaluati...
<p>A, image of tumor-xenografted nude mice model at the end of the treatment. B, tumor size growth c...